Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Cancer Prev Res (Phila). 2010 May 18;3(6):764–775. doi: 10.1158/1940-6207.CAPR-09-0161

Table 1.

Characteristics of intervention group participants in the Polyp Prevention Trial by adenoma recurrence at the end of year 4 (n = 872)

Adenoma Recurrence (T4)
No Advanced High Risk Any

Characteristics Median (IQR) Median (IQR) P value* Median (IQR) P value* Median (IQR) P value*
Sample size 524 49 100 348
Baseline (T0):
Gender (% male) 64 69 0.53 76 0.02 70 0.05
Race (% Caucasian) 88 86 0.64 90 0.73 90 0.58
Education (% ≤ high school) 22 31 0.21 31 0.07 27 0.11
Family history of colorectal 27 27 1.00 30 0.46 26 0.88
Smoker (% current) 11 14 0.48 18 0.07 14 0.21
NSAID use (% yes) 35 31 0.54 33 0.65 37 0.67
Supplement use (%yes) 45 37 0.30 38 0.23 43 0.68
Hormone therapy (% yes) 13 8 0.38 6 0.04 9 0.05
Age (y) 60.0 (52.0–67.0) 66.0 (60.0–71.0) 0.0006 66.0 (58.0–71.0) <.0001 64.0 (57.0–70.0) <.0001
Body mass index (kg/m2) 27.5 (24.8–30.3) 28.6 (26.1–32.4) 0.01 28.3 (25.4–31.1) 0.06 27.6 (25.1–30.6) 0.36
Physical activity (hr/wk)§ 8.50 (4.00–15.1) 7.16 (2.67–12.0) 0.19 8.27 (3.33–13.1) 0.21 8.46 (3.82–16.0) 0.93
Dietary intake:
Alcohol (g/d) 0.92 (0.00–9.78) 0.61 (0.00–2.10) 0.16 0.85 (0.00–8.61) 0.91 0.85 (0.00–10.3) 0.93
Energy (1,000 kcal/d) 1.84 (1.51–2.19) 1.83 (1.51–2.27) 0.91 1.85 (1.57–2.27) 0.40 1.89 (1.55–2.29) 0.10
Fat (% kcal/d) 35.6 (30.1–40.3) 35.8 (31.1–40.5) 0.57 35.4 (30.6–40.2) 0.98 35.6 (30.0–40.7) 0.89
Fat (g/d) 64.0 (49.1–79.8) 67.7 (46.8–81.1) 0.71 67.6 (49.1–81.9) 0.50 67.6 (49.4–83.5) 0.18
Fiber (g/d) 16.8 (12.9–22.9) 16.3 (13.2–23.8) 0.98 17.4 (13.4–23.1) 0.90 17.6 (13.5–22.6) 0.64
Fruits & vegetables (serv./d) 3.44 (2.56–4.67) 3.53 (2.54–4.59) 0.98 3.58 (2.55–4.74) 0.72 3.63 (2.61–4.91) 0.07
Flavonols (mg/d) 14.1 (9.40–20.8) 12.2 (7.83–18.1) 0.11 13.8 (8.65–19.9) 0.51 15.5 (10.1–22.8) 0.05
 Isorhamnetin (mg/d) 0.24 (0.10–0.51) 0.19 (0.10–0.51) 0.49 0.22 (0.12–0.53) 0.98 0.25 (0.13–0.60) 0.06
 Kaempferol (mg/d) 4.74 (2.54–8.04) 3.99 (1.98–5.19) 0.07 4.15 (1.98–7.26) 0.36 4.91 (2.70–9.38) 0.18
 Myricetin (mg/d) 0.83 (0.51–1.44) 0.87 (0.53–1.34) 0.94 0.82 (0.45–1.36) 0.52 0.90 (0.51–1.52) 0.38
 Quercetin (mg/d) 7.48 (5.01–11.3) 6.67 (4.46–10.9) 0.33 7.43 (4.49–11.5) 0.67 8.11 (5.40–11.6) 0.11
Dry beans (g/d) 7.54 (3.27–11.3) 4.90 (3.27–11.3) 0.25 7.00 (1.63–11.3) 0.44 7.54 (3.27–14.0) 0.29
Other vegetables (g/d) 16.8 (3.80–47.0) 12.8 (2.92–45.9) 0.66 16.3 (4.45–48.1) 0.73 21.7 (5.84–55.8) 0.04
Tea (g/d) 0.00 (0.00–72.0) 0.00 (0.00–38.6) 0.49 0.00 (0.00–32.1) 0.40 5.93 (0.00–72.0) 0.46
Apples (g/d) 18.8 (4.61–48.1) 19.7 (4.61–39.4) 0.88 18.4 (4.63–39.4) 0.81 16.6 (6.67–39.4) 0.71
Serological measures (in pg/mL):
Interleukin-6 1.89 (1.36–2.81) 1.77 (1.40–2.62) 0.94 2.04 (1.45–2.75) 0.19 1.91 (1.36–2.92) 0.78
Intervention (T1,2,3 ** ):
NSAID use (% yes) 22 20 1.00 22 0.90 23 0.62
Supplement use (% yes) 35 29 0.35 28 0.17 29 0.07
Hormone therapy (% yes) 11 8 0.64 6 0.15 7 0.08
Body mass index (kg/m2) 26.8 (24.3–29.6) 28.8 (25.6–32.2) 0.004 27.9 (25.2–30.6) 0.01 27.3 (24.6–30.0) 0.18
Physical activity (hr/wk)§ 7.84 (4.19–13.3) 5.13 (2.89–8.25) 0.002 6.92 (4.02–11.5) 0.11 7.51 (4.14–13.5) 0.42
Dietary intake:
Alcohol (g/d) 0.90 (0.00–8.76) 0.98 (0.00–4.93) 0.24 0.98 (0.00–5.63) 0.42 0.96 (0.00–8.26) 0.51
Energy (1,000 kcal/d) 1.78 (1.52–2.09) 1.82 (1.60–1.99) 0.95 1.80 (1.56–1.99) 0.92 1.79 (1.54–2.07) 1.00
Fat (% kcal/d) 22.4 (18.5–26.6) 27.4 (22.2–30.6) 0.0002 25.1 (20.9–30.0) 0.0003 22.9 (19.7–28.1) 0.03
Fat (g/d) 38.9 (31.2–50.0) 47.1 (38.1–55.2) 0.004 44.2 (36.8–52.8) 0.004 41.3 (32.8–51.4) 0.10
Fiber (g/d) 32.1 (24.0–40.8) 29.4 (21.5–37.7) 0.08 29.4 (21.6–36.2) 0.01 30.9 (22.8–39.0) 0.13
Fruits & vegetables (serv./d) 5.72 (4.43–7.15) 4.98 (4.06–6.03) 0.01 5.24 (4.36–6.56) 0.03 5.65 (4.48–6.99) 0.54
Flavonols (mg/d) 29.7 (21.4–40.8) 21.0 (15.0–30.1) 0.0002 25.4 (16.2–36.1) 0.005 29.7 (21.0–38.9) 0.59
 Isorhamnetin (mg/d) 0.73 (0.42–1.10) 0.59 (0.30–0.89) 0.02 0.61 (0.29–0.98) 0.01 0.73 (0.44–1.12) 0.89
 Kaempferol (mg/d) 13.9 (7.83–21.5) 8.27 (5.19–14.4) 0.0002 10.9 (5.40–18.5) 0.01 13.6 (7.89–20.9) 0.40
 Myricetin (mg/d) 0.99 (0.68–1.63) 0.91 (0.62–1.49) 0.18 0.89 (0.56–1.57) 0.06 1.06 (0.65–1.68) 1.00
 Quercetin (mg/d) 13.3 (9.70–16.8) 11.1 (7.55–14.7) 0.007 12.1 (8.01–15.0) 0.01 13.3 (9.58–16.6) 0.98
Dry beans (g/d) 31.2 (15.3–54.6) 14.0 (7.37–35.2) 0.0001 23.0 (8.79–42.1) 0.005 30.3 (14.4–49.5) 0.26
Other vegetables (g/d) 72.3 (37.7–110) 51.5 (23.5–89.5) 0.01 57.5 (22.3–97.7) 0.01 53.5 (29.2–88.5) 0.88
Tea (g/d) 11.9 (0.00–72.0) 3.96 (0.00–48.9) 0.19 0.00 (0.00–55.2) 0.16 9.23 (0.00–40.7) 0.49
Apples (g/d) 57.6 (29.3–89.7) 45.3 (19.7–61.4) 0.03 53.0 (23.9–82.3) 0.33 53.5 (29.2–88.5) 0.79
Serological measures (in pg/mL):
Interleukin-6 (T1) 1.89 (1.29–2.72) 2.03 (1.64–2.86) 0.12 2.27 (1.63–3.19) 0.002 1.92 (1.38–2.90) 0.17
Interleukin-6 (T3) 2.03 (1.40–3.07) 2.21 (1.65–3.20) 0.31 2.44 (1.71–3.50) 0.01 2.05 (1.55–2.94) 0.37
Interleukin-6 (T1,3**) 1.96 (1.43–2.77) 2.11 (1.66–3.07) 0.12 2.33 (1.68–3.26) 0.002 2.05 (1.54–2.90) 0.21
Interleukin-6 (T1–T0) −.06 (−.56–0.39) 0.27 (−.20–0.66) 0.02 0.12 (−.29–0.70) 0.04 0.05 (−.41–0.57) 0.05
Interleukin-6 (T3–T0) 0.07 (−.54–0.67) 0.23 (−.19–0.80) 0.21 0.24 (−.27–0.91) 0.19 0.16 (−.42–0.76) 0.34
Interleukin-6 (T1,3–T0**) 0.03 (−.50–0.51) 0.29 (−.13–0.61) 0.06 0.25 (−.23–0.82) 0.04 0.10 (−.33–0.58) 0.07
*

All comparisons against the no adenoma recurrence group. P values for differences in proportions were calculated using Fisher's exact test. P values for differences in medians were calculated using Wilcoxon rank-sum test.

Family history of colorectal cancer was defined as having ≥ 1 first-degree relative with colorectal cancer at baseline.

Regular dietary supplement use was defined as taking supplement ≥ 1 weekly. Regular medication use, including NSAIDs, was defined as taking medication ≥ 1 monthly. Hormone replacement therapy included both unopposed estrogen and estrogen/progestin combinations.

§

Physical activity was defined as self-reported time typically spent for any type of moderate or vigorous physical activity.

Other vegetables (30% white onions, 5% red onions, 27% cucumbers, 16% celery, 12% radishes, and 10% pepper).

**

T1,2,3: mean values of the first three years of the trial. T1,3 = geometric mean of year 1 and 3 values. T1,3–T0 = T1,3 minus baseline values.